In the context of a brain tumor, it is therefore possible that the TGF-β-induced SHP proteins interact with IFN-γ-induced IDO, resulting in the release of RelB, interaction with Ahr and downstream effects that include the activation of CCL22 transcription (Figure 3). This evidence concerns the gene TGFB1 and brain neoplasm.